While we don’t all suffer from this condition, mild cognitive impairment affects millions of people worldwide and it is a chronic impairment. This study from Vanderbilt University School Of Medicine shows how much nicotine can be helpful in this area. Here are the main elements of this study. This study also supports why nicotine is considered a nootropic for those with or without this impairment.
“Vanderbilt University Medical Center (VUMC) is one of 29 sites participating in a national study to determine whether a daily transdermal nicotine patch will have a positive effect on attention and early memory impairment in older adults diagnosed with Mild Cognitive Impairment (MCI).”
“More than 8 million Americans are currently diagnosed with MCI, a condition that affects memory or other thinking skills. Recent evidence shows that adults with MCI are at a higher risk for subsequently developing Alzheimer’s disease.”
“I am convinced that we will find a way to help improve early memory loss and make a real difference in people’s lives. In this study, we have an inexpensive, widely available potential treatment,” said VUMC’s Newhouse, Jim Turner Professor of Cognitive Disorders and professor of Psychiatry and Behavioral Sciences. Nicotine, a natural plant alkaloid, binds to very specific receptors in the brain that are important for thinking and memory and may have neuroprotective effects.”